Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00615_DB01151_nanopub.RAWlYUOjV_PEQ7A8sad7N4IYKth80whdBRUZ01Lv6XQBE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00615_DB01151 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00615_DB01151 label "DDI between Rifabutin and Desipramine - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, desipramine, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of desipramine if rifabutin is initiated, discontinued or dose changed. [drugbank_resource:DB00615_DB01151]" assertion.
- drugbank_resource:DB00615_DB01151 identifier "drugbank_resource:DB00615_DB01151" assertion.
- drugbank_resource:DB00615_DB01151 title "DDI between Rifabutin and Desipramine - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, desipramine, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of desipramine if rifabutin is initiated, discontinued or dose changed." assertion.
- drugbank:DB01151 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00615_DB01151 assertion.
- drugbank:DB00615 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00615_DB01151 assertion.